Lemborexant Impurity 12 NEW

Lemborexant Impurity 12;1369767-26-9

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

• Product Number: L072012
  English Name: Lemborexant Impurity 12
  English Alias: (1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)cyclopropanecarbaldehyde
  CAS Number: 1369767-26-9
  Molecular Formula: C17H17FN2O2
  Molecular Weight: 300.33
• 
  
• Product Advantages: Lemborexant Impurity 12 has extremely high purity and good chemical stability. As a reference substance, its properties are uniform. Under different experimental environments and detection conditions, it can maintain stable chemical characteristics, effectively ensuring the accuracy, reliability and repeatability of pharmaceutical impurity detection results, and providing a solid reference basis for pharmaceutical quality research.
  Application Fields: It is mainly applied in the quality control and research and development of Lemborexant drugs. As an impurity reference standard, it is used to establish and validate the analytical detection methods of Lemborexant impurities, ensuring the sensitivity and specificity of detection methods. During the drug production process, it is used to monitor the impurity content, assist in optimizing the production process, and prevent excessive impurities from affecting drug quality. In the study of drug stability, it analyzes the changes of this impurity during storage, providing important basis for determining the shelf life and suitable storage conditions of drugs.
  Background Description: As a drug for the treatment of insomnia, the quality of Lemborexant is directly related to the treatment effect and medication safety of patients. Impurities in drugs may interfere with the active ingredients of drugs, affect drug stability, and even bring potential toxic and side effects. Therefore, impurity research is a key part of drug research and development, production and quality control. As a related impurity of Lemborexant, in - depth research on Lemborexant Impurity 12 helps to comprehensively evaluate the quality of Lemborexant drugs and ensure the safety and effectiveness of clinical medication.
  Research Status: Currently, research on Lemborexant Impurity 12 continues to advance. In terms of detection technology, researchers are constantly exploring and optimizing more sensitive and efficient analytical methods, such as Ultra - Performance Liquid Chromatography - Mass Spectrometry (UPLC - MS) technology, to achieve accurate detection of trace impurities. In the study of impurity generation mechanisms, the formation causes and influencing factors of this impurity are deeply explored by simulating the drug synthesis process and storage environment, thus providing a theoretical basis for controlling impurities from the source. At the same time, research on the interaction between this impurity and Lemborexant drugs and its impact on drug efficacy and safety is also gradually carried out, in order to further improve the comprehensive understanding of the quality of Lemborexant drugs.

NOTE！

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery!